In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Refreshes Executive Leadership Team With McCoy Still At Head

This article is powered by The Rose Sheet

Executive Summary

Avon seems intent on dispelling rumors that CEO Sheri McCoy is on her way out, stating June 20 that all planned changes to its executive leadership structure are now complete. New appointments include execs with previous experience at Herbalife and Procter & Gamble.

You may also be interested in...



Unilever Exec Takes Avon's Reins, Says 'Business As Usual' Not An Option

"The Avon Board looks forward to supporting Jan as he leads a deep and comprehensive strategic and operating review of all facets of the business," says Chairman Chan Galbato of Jan Zijderveld's appointment as CEO. Avon's first male CEO in almost 20 years, Zijderveld comes with 30 years of experience at Unilever, where he most recently oversaw its European business.

Avon's Ongoing Struggles Prompt Renewed Investor Call For CEO Ouster

Management projects a strong second half after Avon's first-quarter sales advanced 2%, reported, but dipped in constant currency. Analysts received the guidance guardedly, and a group of investors led by Barington Capital are unconvinced the firm can turn things around under current leadership.

Avon Initiates External Search For CEO As Jung Steps Down

Avon’s Andrea Jung , who will step down from her role as CEO in 2012 but continue on as Executive Chairman, will aid in the search for a candidate to lead the firm. The Dec. 13 announcement has analysts speculating on how the move will impact the performance of the direct seller.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel